1222075-02-6 Usage
General Description
The chemical compound "(3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl" is a complex organic molecule with a tetrahydro-2H-pyran-3,4,5-triyl structure. It contains multiple functional groups, including acetoxyMethyl, thiophen-2-yl, and 4-fluorophenyl. The molecule also includes a combination of methyl and methoxy substituents. The stereochemistry of the compound is specified as (3R,4S,5R,6R), indicating that it has a specific spatial arrangement of its substituents. (3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triyl may have potential applications in medicinal chemistry, pharmaceuticals, or other areas of research that require molecules with specific structural and functional characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1222075-02-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,2,0,7 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1222075-02:
(9*1)+(8*2)+(7*2)+(6*2)+(5*0)+(4*7)+(3*5)+(2*0)+(1*2)=96
96 % 10 = 6
So 1222075-02-6 is a valid CAS Registry Number.
1222075-02-6Relevant articles and documents
Preparation method of canagliflozin
-
, (2020/02/14)
The invention discloses a preparation method of canagliflozin. According to the method, the reaction of each step in a route is improved, so that the conversion rate of raw materials is increased, andintroduction of potential toxic compounds is avoided. In addition, reaction conditions are mild; operation is simple; purity of an obtained product is high; quality of drugs is improved; and the preparation method is suitable for industrial production.
TABLETS CONTAINING A 1-(?-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND
-
, (2016/09/12)
The present invention is directed to a tablet containing a 1-(β-D-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound in high drug loading, in particular, containing the compound ranging from 30 to 95% by weight of tablet and pharmaceutically acceptable additives.
